Table 1.
Baseline characteristics of subjects who underwent ESG and IGB.
| Variables (%) | All (n = 41) | ESG (n = 23) | IGB (n = 18) | P |
| Age (years) | 44.78 ± 11.20 | 47.69 ± 5.06 | 41.06 ± 8.81 | 0.06 |
| Female | 38 (93) | 20 (87) | 18 (100) | 0.11 |
| BMI (kg/m2) | 38.27 ± 5.98 | 41.21 ± 5.38 | 34.50 ± 4.46 | <0.01 |
| Weight (kg) | 105.63 ± 17.92 | 113.40 ± 17.55 | 95.70 ± 13.08 | <0.01 |
| BMI at 3 months (kg/m2) | 33.17 ± 5.45 | 35.76 ± 5.06 | 29.87 ± 4.00 | <0.01 |
| TBWL at 3 months (%) | 13.32 ± 3.50 | 13.30 ± 3.15 | 13.35 ± 3.99 | 0.97 |
| BMI at 6 months (kg/m2) | 32.00 ± 6.07 | 35.34 ± 5.59 | 28.31 ± 4.21 | <0.01 |
| TBWL at 6 months (%) | 16.96 ± 6.03 | 16.17 ± 5.69 | 17.82 ± 6.43 | 0.41 |
| T50 (min) | 83.00 ± 18.81 | 77.03 ± 19.21 | 90.65 ± 15.63 | 0.02 |
| Magnitude of change in %50 (min) at 3 months (pre–post) | 38.39 ± 37.61 | 27.83 ± 24.27 | 54.60 ± 48.47 | 0.02 |
| Volume (mL) | 668.35 ± 287.65 | 744.45 ± 329.07 | 578.82 ± 204.51 | 0.08 |
| Magnitude of change in MTV (mL) at 3 months (pre–post) | 268.00 ± 272.57 | 340.25 ± 297.97 | 183.00 ± 217.13 | 0.08 |
Values were shown as mean ± standard deviation, or n (%). BMI: Body mass index; ESG: Endoscopic sleeve gastroplasty; IGBs: Intragastric balloons; MTV: Maximum tolerated volume; TBWL: Total body weight loss; T50: time for 50% emptying.